“Takte gegen Krebs” of the NCT Heidelberg on November 22: Benefit concert with Uwaga! and two soloists
A musical fusion in three acts - this is what the charity concert “Takte gegen Krebs” by the National Center for Tumor Diseases (NCT) Heidelberg offers on November 22 at the Karlstorbahnhof. The quartet Uwaga!, pianist Sonia Achkar and mezzo-soprano Isabel Pfefferkorn will perform a varied program ranging from classical to jazz and contemporary music. At the ninth edition of this special concert, visitors will once again purchase the bars of the compositions instead of tickets. The proceeds will benefit innovative and applied cancer research at the NCT Heidelberg - www.nct-takte.de.
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), the Medical Faculty of Heidelberg University and the Thorax Clinic Heidelberg.
Wonderful music for a good cause - that is the promise of this year's charity concert “Takte gegen Krebs” by the NCT Heidelberg on November 22 at the Karlstorbahnhof. The program unites three outstanding acts to create a varied musical one-off: the quartet Uwaga!, pianist Sonia Achkar and mezzo-soprano Isabel Pfefferkorn. The six musicians play together throughout the evening and weave different genres into a unique concert experience.
A virtuoso classical violinist with a preference for Eastern European music, a jazz violinist with punk rock experience, a masterfully improvising accordionist with a Balkan sound in his blood and a bassist who feels just as much at home in symphony orchestras as in jazz combos or funk bands - that's the Uwaga! quartet. Active together since 2007, the four musicians have now combined their joy of playing and their different stylistic focuses to create their very own sound.
Pianist Sonia Achkar is a graduate of the Mannheim University of Music and the Jacobs School of Music in the USA. Her playing stands for effortless virtuosity and outstanding musicality. Her multifaceted career and musical versatility have taken Sonia Achkar from renowned concert halls to a concert in Antarctica.
Mezzo-soprano Isabel Pfefferkorn studied in the class for highly gifted singers at the Landeskonservatorium Feldkirch/Vorarlberg and holds a Master's degree from the Zurich University of the Arts. She has won prizes in many competitions. Isabelle Pfefferkorn's repertoire spans all eras and she performs early and contemporary music as well as pop and jazz.
Stefan Fröhling, Managing Director of the NCT Heidelberg and Head of Translational Medical Oncology at the German Cancer Research Center (DKFZ), says: “The exciting program of our benefit concert alone would be a good reason to come to the Karlstorbahnhof. What's more, the guests at the concert evening are supporting the innovative work at the NCT Heidelberg by coming - that's a great thing.”
At the ninth edition of the charity concert, guests will once again purchase bars instead of tickets. At least one bar is required for admission. The proceeds will benefit innovative applied cancer research projects at the NCT Heidelberg. Those who purchase more bars than the required number of seats will make an even greater contribution to supporting the NCT Heidelberg. Tickets at 35 euros each are available via the website www.nct-takte.de.
Dirk Jäger, Managing Director of the NCT Heidelberg and Head of Medical Oncology at Heidelberg University Hospital (UKHD), says: “We would like to thank all visitors to the concert for their support. The proceeds from the benefit concert are an important contribution to advancing research into advanced treatment options for our patients.”
Information at a glance
When: November 22 2024, 7.30 pm, admission at 7 pm
Where: Karlstorbahnhof, Marlene-Dietrich-Platz 3, 69126 Heidelberg
Performers:
Uwaga! quartet https://www.uwagaquartett.de/
Sonia Achkar (pianist) www.soniaachkar.com
Isabel Pfefferkorn (mezzo-soprano) https://www.isabelpfefferkorn.com/
Tickets: www.nct-takte.de or at the box office
Price: 35,00 Euro per bar
Use of proceeds: Innovative applied cancer research projects at the NCT HD
Patronage: Eckart Würzner, Lord Mayor of the City of Heidelberg
Contact:
Regina Hohmann, Donations at the NCT Heidelberg
Tel.: 06221 56-36146; e-mail: fundraising(at)nct-heidelberg.de
A picture of the press release is available free of charge on the Internet at
Note on the use of image material for press releases
Use is free of charge. The NCT Heidelberg permits one-time use in connection with reporting on the topic of the press release. Please indicate the copyright “NCT Heidelberg” as picture credits. The image material may only be passed on to third parties after prior consultation with NCT Communications (phone: +49 6221 42-1755, e-mail: martin.staiger@nct-heidelberg.de). Use for commercial purposes is prohibited.
Contact for the press:
Dr. Martin Staiger
National Center for Tumor Diseases (NCT) Heidelberg
Communication and Events
Im Neuenheimer Feld 460
69120 Heidelberg
Phone: +49 6221 42-1755
E-mail: martin.staiger(at)nct-heidelberg.de
www.nct-heidelberg.de
Dr. Sibylle Kohlstädt
German Cancer Research Center (DKFZ)
Strategic Communication and Public Relations
Im Neuenheimer Feld 280
69120 Heidelberg
Phone: +49 6221 42-2843
Fax: +49 6221 42-2968
E-mail: s.kohlstaedt@dkfz.de
www.dkfz.de
Dr. Stefanie Seltmann
Heidelberg University Hospital and Medical Faculty of Heidelberg University
Press and Public Relations
Im Neuenheimer Feld 672
69120 Heidelberg
Phone: +49 6221 56-5052
Fax: +49 6221 56-4544
E-mail: stefanie.seltmann(at)med.uni-heidelberg.de
www.klinikum.uni-heidelberg.de
The National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center, Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. The pediatric oncologists at the KiTZ work together in joint structures with the NCT Heidelberg.
German Cancer Research Center (DKFZ)
With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.
To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:
- National Center for Tumor Diseases (NCT, 6 sites)
- German Cancer Consortium (DKTK, 8 sites)
- Hopp Children's Cancer Center (KiTZ) Heidelberg
- Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
- DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
- National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.
Heidelberg University Hospital and Faculty of Medicine: Internationally Renowned Patient Care, Research and Teaching
Heidelberg University Hospital (Universitätsklinikum Heidelberg, UKHD) is one of the largest and most prestigious medical centers in Germany. The Medical Faculty of Heidelberg University (Medizinische Fakultät Heidelberg, MFHD) belongs to the internationally renowned biomedical research institutions in Europe. Both institutions have the common goal of developing new therapies and implementing them rapidly for patients. Heidelberg University Hospital and the Medical Faculty of Heidelberg University employs around 14.500 employees and is committed to providing trainings and qualifications. Every year, around 86,000 patients and more than 1.100.000 outpatient cases are treated in more than 50 clinical departments with almost 2.500 beds.
Together with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the German Cancer Aid, the UKHD established the first National Center for Tumor Diseases (NCT) in Heidelberg. The goal is to provide care at the highest level as an oncology center of excellence and to rapidly transfer promising approaches from cancer research to the hospital. In addition, the UKHD operates in partnership with the DKFZ and the University of Heidelberg the Hopp Children’s Cancer center Heidelberg (KiTZ), a unique and nationally known therapy and research center for oncological and hematological diseases in children and adolescents.
The Heidelberg Curriculum Medicinale (HeiCuMed) is one of the top medical training programs in Germany. Currently, there are about 4.000 future physicians studying in Heidelberg.